Andelyn Biosciences

IN THE PRESS

Press Releases

Andelyn Biosciences Announces Partnership with Jaguar Gene Therapy to Provide Late-Stage PPQ Manufacturing

December 8, 2025

·

5 min read

Press Releases

Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101

November 18, 2025

·

8 min read

Press Releases

Andelyn Biosciences and Tern Therapeutics Partner for Late-Stage Process Performance Qualification (PPQ) Manufacturing of AAV Gene Therapy for the Treatment of CLN2 Batten Disease

September 4, 2025

·

3 min read

Press Releases

Andelyn Biosciences and Amplo Biotechnology Partner to Manufacture Novel Gene Therapies for Diseases Affecting the Neuromuscular Junction

August 22, 2025

·

3 min read

Press Releases

Andelyn Biosciences Applies the AAV Curator® Platform to Deliver Novel Gene Therapy for an Ultra-Rare NEDAMSS Disease Patient 14-Months after Diagnosis

May 12, 2025

·

5 min read

Press Releases

Andelyn Biosciences AAV Curator® Platform Used to Manufacture Clinical Grade Viral Vector for FDA-Authorized First-In-World Universal Donor CRISPR/AAV Transduced CAR-NK Cells

May 7, 2025

·

3 min read

Press Releases

Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard

February 19, 2025

·

3 min read

Press Releases

Andelyn Biosciences Selected by Hubble Therapeutics to Manufacture Clinical Grade AAV for the Treatment of Leber Congenital Amaurosis (LCA16)

October 10, 2024

·

4 min read

Press Releases

Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include MyoAAV Plasmids through a License Agreement from the Broad Institute of MIT and Harvard

August 6, 2024

·

3 min read

Press Releases

Andelyn Biosciences Selected by UMass Chan Medical School to Manufacture Clinical Grade AAV9-CSA Vector to Treat Cockayne Syndrome

July 10, 2024

·

4 min read

AWARDS

JOBS